Background. The cytokines induced by Helicobacter pylori, as well as the intricate balance of proinflammatory and anti-inflammatory cytokines, are relevant to the outcomes of H. pylori infection. Transforming growth factor (TGF)-b and interleukin (IL)-10 are 2 vital anti-inflammatory cytokines that regulate mucosal immunity in various inflammatory and infectious diseases.
ferences in host immune responses [2] . In particular, the immune response against H. pylori virulence factors might provide a direct linkage to the development of gastroduodenal diseases [3] .
In the early stages of infection, H. pylori induces the production of chemokines, as well as proinflammatory cytokines [4] . The induction of chemokines or proinflammatory cytokines attracts neutrophils, monocytes, macrophages, or dendritic cells, which then migrate to the inflammatory area and activate a number of innate inflammatory responses. Neutrophils participating in gastric inflammation are related to the clearance of H. pylori [5] . Mucosal macrophages and dendritic cells, the monocyte-derived cells, can capture and digest pathogenic antigens, soon after infection by the pathogen [6] . Furthermore, specific antibodies against H. pylori that are detectable in patients' serum may help eradicate the bacterial infection in gastric mucus [6, 7] .
With respect to cell-mediated immunity, evidence has shown that CD4 + T cells play an important role in protective immunity against H. pylori [8, 9] . However, H. pylori infection is not eliminated in patients with detectable Th1 and antibody responses. It is presumed that the pathogen has evolved a number of strategies to circumvent protective immune responses. In this regard, studies have shown that H. pylori can induce apoptosis of various types of cells, including gastric epithelial cells, macrophages, and T cells [10] [11] [12] . Moreover, the local cytokine milieu, particularly the intricate balance between proinflammatory and anti-inflammatory cytokines, can influence T cell development, the efficacy of immune responses, and gastric pathology [13, 14] . An early and persistent Th1-dominated CD4 response appears to be critical in the prevention of chronic infection but may lead to more severe gastric inflammation [15] . In contrast, the development of chronic infection is linked to a weak or absent H. pylori-specific Th1 response and to the presence of Th2-type cytokines; but only minimal gastritis was found under such conditions [16] . Among known Th2 cytokines, interleukin (IL)-4 and IL-5 were virtually absent from gastric lymphocytes from patients infected with H. pylori [17] [18] [19] .
Recently, transforming growth factor (TGF)-b and IL-10 have been reported to exert potent anti-proliferative and anergy-inducing effects on CD4 cells [20] . Such pathogen-stimulated IL-10 or TGF-b production might play a vital role in the prevention of infection-induced immunopathology or prolongation of persistence, by suppressing Th1 responses [21, 22] . However, only few studies have investigated the effects of H. pylori on TGF-b and IL-10 production and have reported controversial results [23] [24] [25] [26] [27] [28] [29] [30] [31] . We investigated whether H. pylori infection could modulate the production of TGF-b and IL-10 in various mammalian epithelial cells. We show that H. pylori may secrete some soluble protein(s) to induce TGF-b production in gastric epithelial cells and monocytes and that this ability is a constitutional characteristic of H. pylori independent of cagA status and disease status. We assumed that H. pylori might use this capability to escape from or interfere with T cell functions and inflammatory responses.
MATERIALS AND METHODS
Bacterial strains. The H. pylori strains were obtained from ATCC (ATCC 43504) or freshly isolated from gastric biopsy specimens at National Taiwan University Hospital. Clinical isolates were cultured on blood agar plates under microaerobic conditions (5% O 2 , 10% CO 2 , and 85% N 2 ) [32] . After isolation, a single colony was subcultured. The strains were then preserved at Ϫ70ЊC in Brucella broth (Difco Laboratories) supplemented with 15% glycerol (vol/vol). H. pylori strains isolated from 15 patients with chronic gastritis, 15 patients with gastric ulcer, 14 patients with duodenal ulcer, and 15 patients with gastric cancer were randomly selected from more than 300 clinical isolates for further studies. All these strains were determined to be cagA-positive by PCR. The cagA-or vacA-negative isogenic mutants were kindly provided by Professor JinTown Wang [32] . Before the infection of epithelial cells, pure cultures of H. pylori were recovered from stocks cultured on blood agar plates under microaerophilic conditions at 37ЊC for 3 days. The culture plate was washed with 2 mL PBS, and the amount of bacteria suspended in PBS was determined by measuring the optical density at 600 nm.
Bacterial Infection procedure. Epithelial cell lines were seeded in 24-well culture plates in a volume of 1 mL per well and grown at 37ЊC in a 5% CO 2 atmosphere to reach confluence. Prior to infection, each well was washed twice in 1 mL of antibioticfree cell culture medium. Bacterial cells were harvested, washed with PBS and then resuspended in the same medium. The bacteria were added to the cultured cells at an MOI of 400. After incubation for 16 h at 37ЊC in a 5% CO 2 atmosphere, the concentrations of TGF-b or IL-10 in the supernatant were measured at indicated time points. In addition, an uninfected control was included in each experiment. Preparation of soluble extract of H. pylori. H. pylori was harvested, washed and resuspended in PBS ( cfu/mL). 7 4 ϫ 10 Soluble extract was prepared in PBS by sonication, centrifuged at 13,400g for 10 min and passed through a 0.20-mm filter. The protein concentration of soluble extract was determined by the bicinchoninic acid method with bovine serum albumin as a standard.
Preparation of peripheral blood mononuclear cells (PBMCs) and primary gastric epithelial cell lines. Monocytes were isolated from buffy coat prepared from a H. pylori-negative volunteer from our laboratory staff. The plasma of blood samples was carefully removed, PBMCs were prepared with the use of Ficoll-Hypaque density gradient centrifugation and resuspended in RPMI 1640 with 5% inactivated fetal calf serum. Cells were incubated in Petri dishes at 37ЊC for 1 h. Nonadherent cells were removed by several washes with PBS. The ad- herent cells were cultured in RPMI 1640 with 10% fetal calf serum at 37Њ in an atmosphere with 5% CO 2 and 95% humidity.
Primary cultures of human gastric epithelial cells were established from gastric biopsies taken at gastroscopic examinations, as detailed elsewhere [33] . In the experiments to determine TGF-b induction, the concentrations of both primary gastric epithelial cell lines and PBMCs were adjusted to 10 5 cells/mL.
Size exclusion assays. The supernatants from H. pylori were poured into a centrifugal filter device (Amicon Ultra-15; Millipore) with 100-kDa ultrafiltration membranes. The device was centrifuged at 3300g for 30 min, and the supernatant in the upper layer or lower layer was separately collected. The supernatant in the lower layer was later centrifuged again at 1200g for 30 min with a 50 kDa Vivaspin concentrator device (VivaScience) with a 50-kDa ultrafiltration membrane. The protein concentrations of supernatants were measured with a BCA protein assay kit (Pierce), and their TGF-b-inducing activities were determined.
Gel filtration and SDS-PAGE. Fractionation to collect the protein with TGF-b-inducing activity (∼50-100 kDa) was applied on a Sephadex G200 column (Amersham Biosciences). The protein was monitored by Coomassie Plus Bradford assay with absorbance set at 595 nm. Gel filtration was carried out at room temperature with the buffer containing 1x PBS (pH, 7.4). Every 5 fractionations (5 mL/fraction) collected by gel filtration were mixed, and the TGF-b-inducing ability was examined in AGS cells. The TGF-b-producing fraction was then subjected to 10% SDS-PAGE electrophoresis. The gels were later stained with Coomassie blue and their molecular equivalent masses were determined by comparing them with standard markers.
Quantitation of TGF-b and IL-10. TGF-b and IL-10 proteins in the supernatant were measured with ELISA kits purchased from Promega and used according to the manufacturer's instructions.
Statistical analysis. Triplicate results of 3 experiments ( ) are expressed as mean values ‫ע‬ SEM. Statistical difn p 9 ferences were determined with the software program Schoolstat (White Ant Occasional Publishing) using overall analysis of variance and the independent t test. level at 90 min, and remained at this high level till the end of the experiment (16 h after infection) (figure 1B). Production of TGF-b in AGS cells was noted to depend on the size of the inoculum; the plateau was found to be at an MOI value of 400 ( figure 1C) . On the basis of these results, the following analyses of H. pylori-induced TGF-b production were performed using an MOI value of 400 and an incubation period of 16 h, unless otherwise stated.
RESULTS

Induction
Induction of TGF-b production by H. pylori, according to cagA, vacA and the disease status. H. pylori could significantly increase the production of TGF-b in various mammalian nongastric cell lines ( ) ( figure 2A ). In contrast, there was P ! .05 no alteration in the IL-10 level after culture of H. pylori with various mammalian cell lines (data not shown). The induction of TGF-b in epithelial cells was specific to H. pylori, because other enteric bacteria (E. coli, K. pneumoniae, E. cloacae, P. aeruginosa, S. flexneri, and group B Salmonella) did not induce TGF-b production (figure 2B). There was no strain variability with respect to TGF-b production: cultures of AGS cells with various H. pylori strains isolated from patients with gastritis, duodenal ulcer, gastric ulcer, or gastric cancer showed no significant difference in the mean level of TGF-b (figure 2C). Furthermore, TGF-b production was similar between cagAnegative isogenic mutants and cagA-positive strains ( figure 2D) .
Induction of TGF-b by soluble proteins of H. pylori. Stimulation of AGS cells with soluble and insoluble fractions of live and dead H. pylori showed that only the insoluble fraction could not induce TGF-b production (figure 3). To further determine whether the modulatory factors present in H. pylori preparations were protein or nonprotein factors, the soluble lysate was pretreated with boiling. After boiling, the capability of induction of TGF-b was significantly decreased (figure 3). Furthermore, digestion of the supernatant with proteinase K completely stopped TGF-b production, indicating that soluble proteins account for the inducing effect (data not shown).
Induction of TGF-b by the soluble proteins of H. pylori in PBMCs and gastric epithelial cells. Although epithelial cells from cancer cell lines can be stimulated to express TGF-b, whether the normal gastric epithelial cells and PBMCs can respond to H. pylori is unknown. Therefore, the human primary gastric epithelial cells were incubated with H. pylori or the soluble supernatant to monitor the secretion of TGF-b into medium. The results revealed that H. pylori and its soluble proteins could induce TGF-b secretion in the gastric epithelial cells and in PBMCs, but E. coli could not ( figure 4A and 4B) .
Partial characterization of the TGF-b inducing factor(s). TGF-b inducing activity was detectable in the retentate after concentration with a 50-100 kDa-cutoff concentrator (results not shown). After eluates that passed through the 100-kDa filter were reseparated with the gel filtration column, and the TGF-b inducing activities in the fractions were determined (figure 5A), SDS-PAGE analysis of fractions with peak TGF-b inducing activity revealed 2 major bands with a molecular mass of ∼70 kDa (figure 5B).
DISCUSSION
The mechanisms by which H. pylori causes chronic infection and interacts with immune systems remain unclear. Proinflammatory cytokines, particularly Th1 cytokines, have long been considered as the main mediators of the immune response to H. pylori infection [34] . In view of the recent findings on the critical role of anti-inflammatory cytokines in diverse pathogens [20] , this study focuses on the anti-inflammatory cytokines TGF-b and IL-10. We first demonstrated that TGF-b, rather Several studies in which H. pylori and epithelial cell lines have been cultured together yielded contradictory findings: both increased IL-10 production and no change of IL-10 production have been found [23] [24] [25] [26] . This discrepancy may be the result of different experimental conditions, such as differences in bacteria strains, cell lines, host-bacteria interaction, and methods of quantitation (eg, use of reverse-transcription PCR or ELISA). In a recent publication, Nakachi et al. [30] found that H. pylori infection did not increase the levels of TGF-b mRNA in human gastric epithelial cells. However, Takagi et al. [28] have demonstrated that TGF-b was produced by gastric cancer cells after exposure to H. pylori. In agreement with the latter report, our results show that H. pylori induced a rapid accumulation of TGF-b in various cell lines. It is important to note that H. pylori also stimulated TGF-b production in primary gastric epithelial cells and PBMCs. Because PBMCs comprise a major part of the cellular inflammatory response to H. pylori infection, our finding for PBMCs strengthens the importance of the TGF-b in vitro model. Further evidence for the involvement of TGF-b in H. pylori infection was found by immunohistochemical staining of gastric biopsy specimens. Compared with cells from uninfected subjects, cells from H. pylori-infected patients have significantly higher TGF-b levels [35] . Moreover, Messa et al. [29] have demonstrated that TGFb expression dropped remarkably after successful eradication of H. pylori. Confirming these observations, our data suggest that H. pylori infection can induce TGF-b production in epithelial cells and PBMCs.
The phenomenon of TGF-b induction by H. pylori is quite unique, and different from the findings for other commonly isolated enteric pathogens. Only H. pylori can influence the release of TGF-b by the gastric epithelial cells. Intriguingly, the target of the TGF-b-inducing protein exists in not only gastric epithelial cells but also other types of cell. It implies that the ability to induce the secretion of TGF-b is specific to H. pylori, but the receptor for the modulating factor may be expressed on different cells.
Previous studies have demonstrated that cytokine production is dependent on direct contact between epithelial cells and bacteria [23] [24] [25] [26] [27] [28] and is influenced by bacterial strains with an intact cag pathogenicity island [36] . The results of our study suggest that the capability to induce TGF-b production can be regarded as a constitutional characteristic of H. pylori, because all strains from different disease status show this activity. There was no relation between the inducing activity and the cagA or vacA status of the strain.
The induction of TGF-b by H. pylori probably has biological significance, in view of the central role of TGF-b in immune regulation [37] . As a regulator of site-specific T cell inflammatory response [21] , TGF-b is relevant in gastric pathology during H. pylori infection. By its immunosuppressive function, TGF-b may protect the gastric mucosa from severe damage caused by gastritis, in one way, and contribute to the persistence of H. pylori infection, in another. The role of TGF-b is also elusive in other infectious and inflammatory bowel diseases [38, 39] . Buzoni-Gatel et al. [37] have shown that the regulation of the ileal inflammatory process in T. gondii infection is dependent on TGF-b-producing intraepithelial lymphocytes. In colitis, TGF-b production is an essential mechanism of counterregulation of Th1 cell-medicated mucosal inflammation [39] . In addition, perturbation of TGF-b signaling in animal models is linked to development of severe mucosal inflammation of gastrointestinal tract [40, 41] . In patients with H. pylori-related duodenal ulcer, TGF-b production in the metaplastic epithelium of the duodenum is decreased, compared with production in nonmetaplastic epithelium [31] . Pathogen-stimulated TGFb production in innate cells might prevent infection-induced immunopathology or prolong pathogen persistence by suppressing protective Th1 responses [20] .
In accordance with previous reports and our data, we propose a hypothetical explanation of the persistence of H. pylori infection in the face of strong immune responses. We speculate that H. pylori, through the induction of TGF-b, might construct an immune privileged area in the stomach that mimics the ocular microenvironment, where immune effector responses and inflammation are suppressed [22] . Then the organisms protect themselves in the acidic environment with urease. However, the adhesion would alert the host immune system and induce proinflammatory cytokines and chemokines to trigger the migration of immune cells to the gastric epithelium. To prevent destruction by these immune responses, H. pylori secretes TGF-b-inducing protein to induce TGF-b production, and the gastric epithelial cell-derived TGF-b diffuses in the gastric epithelium to protect H. pylori from the immediate immune attack at the early stage of infection. Moreover, the secreted TGF-b-inducing protein will interact with macrophages to trigger the second burst of TGF-b secretion, which causes more-extensive immunosuppression. The macrophages expressing TGF-b may interact with T cells to induce anergy. As the H. pylori bacteria invade further, they magnify the TGFb-dependent immune-privileged area. Therefore, although the immune effectors will be attracted by chemokines, immune cells might lose their activity once they enter the TGF-b-inducing, protein-induced, immune-privileged area. The significance of TGF-b and TGF-b-inducing protein for the pathogenesis of H. pylori-related diseases remains speculative at present. Nevertheless, it is potent and worth investigating in future studies.
